Loblaw Companies Limited · TSX:L
Loblaw Companies — Q3 2017 Earnings Presentation
6 slides from Loblaw Companies's earnings presentation, Nov 15, 2017
Slide 1: Q3 2017 Supplementary Slides
Q3 2017 Supplementary Slides November 15, 2017 1
Slide 2: Forward-looking Statements
Forward-looking Statements This presentation for Loblaw Companies Limited (“Loblaw” or “the Company”) contains forward-looking statements about the Company’s objectives, plans, goals, aspirations, strategies, financial condition, results of operations, cash flows, performance, prospects, opportuniti
Slide 3: Key Financial Metrics Q3 - Consolidated
Key Financial Metrics Q3 Consolidated 2017 Margin/Growth B/(W) Consolidated Revenue $ 14,192M +0.3% (excluding disposition of gas bar operations) approx. +3.0% Adjusted EBITDA and Margin $ 1,229M 8.7%/+7.5% +60bps (excluding disposition of gas bar operations) approx.+9.4% approx. +50bps Adjusted Dil
Slide 4: Key Financial Metrics Q3 - Retail Segment
Key Financial Metrics Q3 Retail Segment 2017 Margin/Growth B/(W) Total Retail Revenue $ 13,923M +0.2% (excluding disposition of gas bar operations) approx. +3.0% Retail Revenue - Food Retail $ 10,172M -1.0% (excluding disposition of gas bar operations) approx. +2.6% Retail Revenue - Drug Retail $ 3,
Slide 5: Key Operational Metrics Q3 - Food Retail (Loblaw)
Key Operational Metrics Q3 Food Retail (Loblaw) 2017 Food Retail SSS Growth ex gas bar 1.4% Basket Size Traffic Internal Food Price Index Loblaw Food Price Index was marginally higher than CPI of 0.3% Loblaw STM Square Footage Growth Industry STM Square Footage Growth 5
Slide 6: Key Operational Metrics Q3 - Drug Retail (Shoppers Drug Mart)
Key Operational Metrics Q3 Drug Retail (Shoppers Drug Mart) 2017 Pharmacy Sales $ 1,820M +5.1% Pharmacy SSS +3.9% # Rx Dispensed (Rx Count) Absolute + 4.9% Same-store basis +4.3% Average Rx Value -0.6% Front of Store Sales $ 1,931M +2.7% Front of Store SSS +2.8% 6